Infection Control Surveillance Solutions Market - Databook 2025 to 2034

The global infection control surveillance solutions market size was calculated at USD 834 million in 2024 and is predicted to attain around USD 3,523.59 million by 2034, expanding at a CAGR of 15.5% from 2025 to 2034.

Highlights of the Infection Control Surveillance Solutions Market

• North America dominated the global market in 2024.
• Asia Pacific is anticipated to grow at the fastest rate in the market during the forecast period.
• By component insight, the software segment held a dominant presence in the market in 2024.
• By component insight, the services segment is expected to grow at the fastest rate in the market during the forecast period of 2025 to 2034.
• By end-user insight, the hospitals segment led the cold storage market.
• By end-user insight, the specialty surgical centers segment is set to experience the fastest market growth rate from 2025 to 2034.

Industry Valuation and Growth Rate Projection

The market for infection control surveillance solutions is expected to grow, owing to the need for ensuring patient safety and preventing healthcare-associated infections (HAIs). The solutions help protect the healthcare institution from infection risks by monitoring and detecting them, and thereby ensuring better clinical outcomes and operational efficiency. It is a positive factor for the market that healthcare IT infrastructure and related digital healthcare technologies are being rapidly developed.

With the help of real-time data tracking, enhanced reporting, and quicker response to potential outbreaks, these systems have become an indispensable tool in today's healthcare settings. The lengthening days of hospital stay due to chronic and infectious diseases gave rise to the need for sound infection surveillance. Rising healthcare expenditure and support in the area of infection prevention technologies are accelerating the growth of this market. Governmental mainstream initiatives as well as regulatory compliance schemes further support the growth of these solutions and, hence, these solutions have been integrated into the hospital management strategies.

Infection Control Surveillance Solutions Market: Stats and Figures

• Overall, there was approximately a 13% decrease in CLABSI between 2022 and 2023.
• Decreases were observed in all location settings: ICU (20%), NICU (13%), and Wards (8%).
• Overall, there was an 11% decrease in CAUTI between 2022 and 2023.
• Decreases were noted across ICU locations (16%) and Ward locations (8%).
• Overall, there was a 5% decrease in VAE between 2022 and 2023.
• A 5% decrease was observed in ICU locations.
• However, a 9% increase was noted in Ward locations.
• Overall, there was a 3% increase in SSI combined SCIP procedures between 2022 and 2023.

How AI Has Benefitted the Infection Control Surveillance Solutions Market?

• Predictive Analytics for Early Detection: AI processes large volumes of data to detect high-risk patients and predict infections.
• Automated Surveillance System: AI monitors EHR and patient data for detecting healthcare-associated infections.
• Personalized Infection Control: AI attempts to create personalized infection control strategies based on individual patient data.
• AI-Enhanced Decision Support: Helps clinicians make better decisions, particularly in antimicrobial stewardship.
• Operational Efficiency and Patient Safety: AI automates routine hospital tasks while enhancing infection surveillance.
• Advanced AI Services: Includes robotic disinfection; pattern recognition for hand hygiene, complaints, and outbreak detection; NLP for clinical notes; and computer vision for hand hygiene monitoring.

Industry Leader Announcements

• Dr Ohmagari, Director of the AMR Clinical Reference Center in Tokyo :

“Our collective efforts led to periods with no MRSA cases detected, demonstrating that proper infection control measures could prevent drug-resistant bacterial infections.”

• Alexander Sundermann, DrPH, CIC, FAPIC, an assistant professor in the Division of Infectious Diseases at the University of Pittsburgh Center for Genomic Epidemiology and a member of Infection Control Today’s Editorial Advisory Board:

“With our prior publication, two real-time bacterial genomic surveillance systems can detect multiple health care outbreaks that go otherwise undetected, guide interventions, stop outbreaks, reduce infections, and save net costs. We think this will soon become routine in hospitals.”

Geographical Insights

Which region dominated the Infection Control Surveillance Solutions Market?

North America dominated the infection control surveillance solution market with APAC being fastest fastest-growing region.

North America

The developed healthcare infrastructure and inclination towards patient safety in North America dominate the infection control surveillance solutions market. Surveillance technologies are broadly accepted due to the increasing healthcare expenditure in the region and growing awareness about infection prevention. The growing occurrence of hospital-acquired infections leads healthcare providers to outfit more advanced systems for real-time surveillance and early detection. Such importance is reinforced by government support and regulatory requirements on infection control.

Asia-Pacific

The APAC region is expected to witness strong growth in infection control surveillance solutions markets owing to its burgeoning population, increased demand for quality healthcare, and greater attention toward preventing infectious diseases. Investments towards healthcare infrastructure and increasing digital interventions and software in hospitals and clinics are contributing to market expansion in the region. The demand for infection control technologies is further supported by emphasis on creating safer healthcare environments for the staff and patients.

Europe

Europe holds a significant market share backed by advanced healthcare systems and regulatory frameworks. The market continues to grow steadily due to the commitment of the region towards infection prevention and integration of technology in clinical environments.

Recent Developments:

• In February 202, KLAS Research rated Sentri7 clinical surveillance solution as Best in KLAS® for infection control and monitoring in the 2025 Best in KLAS – Software and Services report.

Competitive Landscape

The market is moderately fragmented with local players like Becton, Dickinson and Company, Premier Inc., Wolters Kluwer N.V, Gojo Industries, RL Solutions, Baxter International Inc., Premier Inc., Truven Health Analytics (An IBM Company), etc., wishing to take the time to edge their presence through investments, partnerships, acquisitions, and mergers. They also invest in product development and competitive pricing. These strategies will promote market growth and lucrative opportunities for market players

• Company Name: Becton Dickinson
• Year of Incorporation: 1897
• Headquarters: Franklin Lakes, New Jersey, USA.

According to Becton Dickinson's latest financial reports, the company's current revenue (TTM) is ₹1.765 trillion. An increase in revenue in the year 2023, that were of ₹1.622 Trillion.

• Company Name: Premier Inc.
• Year of Incorporation: 2013
• Headquarters: Charlotte, North Carolina, U.S.

Premier Inc.'s annual revenue for the fiscal year ending June 30, 2024, was $1.346 billion. This represents a 1% increase compared to the previous year's revenue of $1.336 billion.

• Company Name: Baxter International Inc.
• Year of Incorporation: 1931
• Headquarters: Deerfield, Illinois, USA

Baxter International's annual revenue for 2024 was $10.64 billion. This represents a 3% increase on both a reported and constant currency basis compared to the previous year.